Clinical Trial Update: Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM [Phase 1]

View source ↗

Summary

Phase 1 trial update of CMV Towne vaccine in subjects previously given VCL CT02 vaccine; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• CMV Towne Vaccine (Cytomegalovirus Towne vaccine)
• VCL CT02 Vaccine (VCL CT02 cytomegalovirus vaccine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Cytomegalovirus Infection | Phase 1 | Status: COMPLETED